Cancer Therapy
Investigators at University of Leipzig publish new data on cancer therapy
Published in Oncology Business Week, December 31st, 2006
A report, "Selectins - potential pharmacological targets," is newly published data in Drug Discovery Today. According to recent research from Leipzig, Germany, "Recent advances in our (patho)physiological understanding have underpinned the frequent involvement of the protein family of selectins in the progression of serious illnesses, including cancer and cancer metastasis, and immunological diseases, such as asthma, allergy and autoimmune reactions."
"Moreover, selectins seem to have a role in post-ischemic damage and during transplant failures (e.g. in graft-versus-host disease). Although the interplay between selectins and their counter-receptors and ligands is not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Actinic Keratosis
Australian government approves registration of Solaraze 3% gel for carcinoma in situ - Awards
DxS receives Biotechnology Award for cancer product from BioNow - Breast Cancer
Study shows Confirma's CADstream may increase confidence in breast MRI interpretation - Breast Cancer Genetics
Research in the area of breast cancer genetics reported from Memorial Sloan Kettering Cancer Center - Breast Cancer Risk Factors
Recent findings in breast cancer risk factors described by investigators from Kaiser Permanente, Division of Research - Breast Cancer Screening
Reports from Siemens AG describe recent advances in breast cancer screening - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
